scientifyRESEARCH
research funding database

RESEARCH FUNDING

Analytical and Clinical Validation of Biomarkers for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)

Share this post

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.

The Analytical and Clinical Validation of Biomarkers for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional) from the National Institutes of Health (NIH) supports research to accelerate the establishment of effective and reliable biomarkers of Alzheimer’s disease (AD) and AD-related dementias (ADRD) for use in therapy/medical product discovery and development, clinical trials, and/or clinical practice. Applications are open to researchers at research institutions in the USA and worldwide, including small businesses and other for-profit organizations. The grant provides funding for up to 4 years. There are no budget limitations but the proposal must reflect the actual needs of the proposed project.

Funding opportunity number: PAR-23-258.

Letters of intent are due on September 5, 2024 and full applications are due on October 5, 2024.

Full application due:
October 5, 2024

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time

Be the first to know

Sign-up for Personalized Grant Alerts

Logo3